￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

medicaldrugs

Summary of telisotuzumab-EMRELIS clinical trial data and efficacy analysis for different indications

2026-02-01 22:25:32

Check Details
Whether tovorafenib will be included in the medical insurance catalog in 2026 and its reimbursement policy and cost reference instructions

2026-02-01 22:25:32

Check Details
How many days does a course of vorasidenib-VORANIGO require and detailed instructions on dosage schedule and usage plan?

2026-02-01 22:25:32

Check Details
Comparative analysis of the differences, indications, efficacy and safety between Zongertinib and Trastuzumab

2026-02-01 22:25:32

Check Details
Full explanation of vosoritide reimbursement conditions, medical insurance policies, patient fees and purchase process

2026-02-01 22:25:32

Check Details
Pralsetinib has rewritten the treatment landscape for lung cancer. How do Chinese patients cope with the high costs of not being covered by medical insurance?

2026-02-01 22:25:32

Check Details
Category
相关知识